Synopsis
Synopsis
0
USDMF
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Depressan
2. Dihydralazine
3. Dihydrallazine
4. Dihydrazinophthalazin
5. Sulfate, Dihydralazine
1. 7327-87-9
2. Dihydralazine Sulphate
3. Depressan
4. 1,4-dihydrazinophthalazine Sulfate
5. Hydralazine Sulfate
6. 1,4-dihydrazinylphthalazine Sulfate
7. Nepresol
8. Ophthazin
9. 1,4-dihydrazinophthalazine Hydrogen Sulfate
10. (4-hydrazinylphthalazin-1-yl)hydrazine;sulfuric Acid
11. 1c2b1w91nk
12. Ophthazin Sulfate
13. Ccris 5386
14. Sulfate De Dihydralazine [french]
15. Sulfate De Dihydralazine
16. Einecs 230-808-0
17. Unii-1c2b1w91nk
18. Dihydralazinsulfat
19. Phthalazine, 1,4-dihydrazino-, Sulfate (1:1)
20. Nepresol (tn)
21. Dihydralazine Sulfate,(s)
22. Dihydralazine Hydrogen Sulfate
23. Schembl1374523
24. Chembl2106266
25. Dtxsid10223501
26. Dihydralazine Sulfate [mi]
27. Bcp11859
28. Dihydralazine For System Suitability
29. Hy-n7065
30. Mfcd00035271
31. S5030
32. Dihydralazine Sulfate [mart.]
33. Akos015960760
34. Akos037643215
35. Dihydralazine Sulfate [who-dd]
36. Ccg-267357
37. Cs-w012211
38. Sb67406
39. Ac-12152
40. As-10957
41. Ft-0731572
42. (4-hydrazinylphthalazin-1-yl)hydrazine Sulfate
43. C76337
44. D07830
45. 327d879
46. A920291
47. 1,4-dihydrazinophthalazine Hydrogen Sulphate
48. W-104459
49. Q27252218
Molecular Weight | 288.29 g/mol |
---|---|
Molecular Formula | C8H12N6O4S |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 2 |
Exact Mass | 288.06407406 g/mol |
Monoisotopic Mass | 288.06407406 g/mol |
Topological Polar Surface Area | 185 Ų |
Heavy Atom Count | 19 |
Formal Charge | 0 |
Complexity | 248 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Market Place
ABOUT THIS PAGE
A Dihydralazine Sulfate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dihydralazine Sulfate, including repackagers and relabelers. The FDA regulates Dihydralazine Sulfate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dihydralazine Sulfate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dihydralazine Sulfate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dihydralazine Sulfate supplier is an individual or a company that provides Dihydralazine Sulfate active pharmaceutical ingredient (API) or Dihydralazine Sulfate finished formulations upon request. The Dihydralazine Sulfate suppliers may include Dihydralazine Sulfate API manufacturers, exporters, distributors and traders.
click here to find a list of Dihydralazine Sulfate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dihydralazine Sulfate CEP of the European Pharmacopoeia monograph is often referred to as a Dihydralazine Sulfate Certificate of Suitability (COS). The purpose of a Dihydralazine Sulfate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Dihydralazine Sulfate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Dihydralazine Sulfate to their clients by showing that a Dihydralazine Sulfate CEP has been issued for it. The manufacturer submits a Dihydralazine Sulfate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Dihydralazine Sulfate CEP holder for the record. Additionally, the data presented in the Dihydralazine Sulfate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Dihydralazine Sulfate DMF.
A Dihydralazine Sulfate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Dihydralazine Sulfate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Dihydralazine Sulfate suppliers with CEP (COS) on PharmaCompass.
A Dihydralazine Sulfate written confirmation (Dihydralazine Sulfate WC) is an official document issued by a regulatory agency to a Dihydralazine Sulfate manufacturer, verifying that the manufacturing facility of a Dihydralazine Sulfate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Dihydralazine Sulfate APIs or Dihydralazine Sulfate finished pharmaceutical products to another nation, regulatory agencies frequently require a Dihydralazine Sulfate WC (written confirmation) as part of the regulatory process.
click here to find a list of Dihydralazine Sulfate suppliers with Written Confirmation (WC) on PharmaCompass.
Dihydralazine Sulfate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dihydralazine Sulfate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dihydralazine Sulfate GMP manufacturer or Dihydralazine Sulfate GMP API supplier for your needs.
A Dihydralazine Sulfate CoA (Certificate of Analysis) is a formal document that attests to Dihydralazine Sulfate's compliance with Dihydralazine Sulfate specifications and serves as a tool for batch-level quality control.
Dihydralazine Sulfate CoA mostly includes findings from lab analyses of a specific batch. For each Dihydralazine Sulfate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dihydralazine Sulfate may be tested according to a variety of international standards, such as European Pharmacopoeia (Dihydralazine Sulfate EP), Dihydralazine Sulfate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dihydralazine Sulfate USP).
LOOKING FOR A SUPPLIER?